- Home
- ABEO vs RCAT Comparison
ABEO vs RCAT Comparison
Compare ABEO & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABEO | RCAT |
|---|---|---|
| Founded | 1974 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Wholesale Distributors |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 1.9B |
| IPO Year | 2005 | 2017 |
Fundamental Metrics
Financial Performance| Metric | ABEO | RCAT |
|---|---|---|
| Price | $4.31 | $16.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $18.75 | ★ $20.00 |
| AVG Volume (30 Days) | 1.3M | ★ 18.8M |
| Earning Date | 03-17-2026 | 03-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 165.16 | N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | $2,998,000.00 | ★ $17,836,382.00 |
| Revenue This Year | $1,276.65 | $251.35 |
| Revenue Next Year | $112.53 | $28.87 |
| P/E Ratio | $4.41 | ★ N/A |
| Revenue Growth | ★ 258.18 | 79.95 |
| 52 Week Low | $3.93 | $4.60 |
| 52 Week High | $7.54 | $18.78 |
Technical Indicators
Market Signals| Indicator | ABEO | RCAT |
|---|---|---|
| Relative Strength Index (RSI) | 31.31 | 56.44 |
| Support Level | $4.00 | $10.39 |
| Resistance Level | $5.52 | $17.83 |
| Average True Range (ATR) | 0.23 | 1.93 |
| MACD | -0.07 | -0.06 |
| Stochastic Oscillator | 4.90 | 55.17 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About RCAT Red Cat Holdings Inc.
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.